(Q40106425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

review article

1 reference

title

Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin—Current status (English)

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

24 August 2023

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 June 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:0016508583903888?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

https://api.elsevier.com/content/article/PII:0016508583903888?httpAccept=text/plain

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

24 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1602-1613

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188645%20AND%20SRC:MED&resulttype=core&format=json

Distribution of immunoassayable glucagon in gastrointestinal tissues

28 October 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Demonstration and Characterization of a Second Fraction of Glucagon-Like Immunoreactivity in Jejunal Extracts

24 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose

24 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Effect of vasoactive intestinal polypeptide on glycogen metabolism in rat hepatocytes

24 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Extrapancreatic Glucagons

24 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Heterogeneity of extractable gut glucagon-like immunoreactivity (GLI) and its lipolytic activity

24 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Physicochemical and biological properties of glucagon-like polypeptides from porcine colon

24 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The insulin releasing activities of extracts of pork intestine

24 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Isolation of glucagon-like immunoreactivity of gut by affinity chromatography on anti-glucagon antibodies coupled to sepharose 4 B.

24 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity

24 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranes

24 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase

24 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Identification of glucagon in the gastrointestinal tract

24 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity

24 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Evidence that glicentin contains the entire sequence of glucagon

24 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The primary structure of porcine glicentin (proglucagon)

24 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Processing mechanisms in the biosynthesis of proteins

24 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Sequence analysis of porcine gut GLI-1.

24 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Isolation of a glucagon-containing peptide: primary structure of a possible fragment of proglucagon

24 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Relationship of glicentin to proglucagon and glucagon in the porcine pancreas

24 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Purification and chemical characterization of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas

24 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

24 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities

24 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glicentin: A precursor of glucagon?

24 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glicentin Immunoreactive Cells: Their Relationship to Glucagon-Producing Cells*

24 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glucagon- and glicentin-immunoreactive cells in the human digestive tract

24 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

24 August 2023

Biosynthesis of glucagon

41

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Identification and processing of proglucagon in pancreatic islets

24 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The major proglucagon fragment: an abundant islet protein and secretory product

24 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glucagon precursors identified by immunoprecipitation of products of cell-free translation of messenger RNA.

24 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Cell-free synthesis and processing of multiple precursors to glucagon

24 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem

24 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Isolation and partial characterization of anglerfish proglucagon

24 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Intestinal glucagon mRNA identified by hybridization to a cloned islet cDNA encoding a precursor

24 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Immunocytochemical localization of a gastric inhibitory polypeptide-like material within A-cells of the endocrine pancreas

24 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Is GIP a glucagon cell constituent?

24 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas

24 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glucagon and glicentin immunoreactivity are topologically segregated in the α granule of the human pancreatic A cell

24 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Transformation of glicentin-containing L-cells into glucagon-containing cells by enzymatic digestion

24 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The purification and biological properties of pancreatic big glucagon

24 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours

24 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Effect of Endogenous Intestinal Glucagon-like Immunoreactivity (GLI) on Insulin Secretion and Glucose Concentration in Dogs1

24 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Plasma Enteroglucagon after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio

24 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Intestinal adaptation after jejunoileal bypass in man

24 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity

24 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Gut-hormone profile in totally pancreatectomised patients

24 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs

24 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy

24 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat

24 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia

24 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The hormonal pattern of intestinal adaptation. A major role for enteroglucagon

24 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Gut hormones in tropical malabsorption

24 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Gut-hormone profile in coeliac disease

24 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Changes in N-terminal glucagon-like immunoreactivity and insulin during short-term gluten challenge in childhood coeliac disease

24 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Plasma enteroglucagon and plasma volume change after gastric surgery

24 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Relationship between insulin and gut glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects

24 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients

24 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Anomeric Specificity in the Response of Gut Glucagon-like Immunoreactive Materials to Glucose

24 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Release of Gut GLI by Luminal Hypotonicity

24 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs

24 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Gastric A-cell function in insulin-deprived depancreatized dogs

24 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Response of extrapancreatic glucagon to arginine in dogs

24 August 2023

84

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glucagon secretion in four duodenopancreatectomized patients after arginine and glucose load

24 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Effect of bombesin infused intrapancreatically on glucagon and insulin secretion

24 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.

24 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Bombesin: action on gut hormones and calcium in man

24 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat

24 August 2023

90

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man

24 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin

24 August 2023

92

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Effect of acetylcholine on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in pancreatectomized dogs

24 August 2023

93

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

The Use of Perfused Rat Intestine to Characterise the Glucagon-Like Immunoreactivity Released into Serosal Secretions Following Stimulation by Glucose

24 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Chromatographic Pattern of Gut Glucagon-Like Immunoreactivity (GLI) in Plasma before and during Glucose Absorption

24 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Molecular Size of Extractable Glucagon and Glucagon-like Immunoreactivity (GLI) in Plasma

24 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action

24 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity

24 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Glicentin inhibits gastric acid secretion in the rat

24 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Evidence for Transformation of Glucagon-Like Immunoreactivity of Gut into Pancreatic Glucagon In Vivo

24 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes

24 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Effects of glicentine on insulin secretion

24 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

INCREASED GUT GLUCAGON RELEASE AS PATHOGENETIC FACTOR IN REACTIVE HYPOGLYCqMIA?

24 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

A Possible Role for Gut GLI: an Inhibitor of Lipolysis

24 August 2023

110

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function

24 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

24 August 2023

An enteroglucagon tumour

112

1 reference

https://api.crossref.org/works/10.1016/0016-5085(83)90388-8

24 August 2023

Identifiers

1 reference